CB
TEVA icon

Commerce Bank’s Teva Pharmaceuticals TEVA Stock Holding History

Commerce Bank’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-10,458
Closed -$164K – 936
2019
Q1 		$164K Buy
10,458
+303
+3% +$5.34K ﹤0.01% 859
2018
Q4 		$157K Hold
10,155
– – ﹤0.01% 828
2018
Q3 		$218K Sell
10,155
-109
-1% -$2.53K ﹤0.01% 823
2018
Q2 		$250K Sell
10,264
-54
-0.5% -$1.1K ﹤0.01% 777
2018
Q1 		$176K Sell
10,318
-8,150
-44% -$159K ﹤0.01% 822
2017
Q4 		$350K Sell
18,468
-4,066
-18% -$61.2K ﹤0.01% 674
2017
Q3 		$397K Sell
22,534
-460
-2% -$10.3K 0.01% 625
2017
Q2 		$764K Sell
22,994
-14,684
-39% -$455K 0.01% 436
2017
Q1 		$1.21M Sell
37,678
-9,139
-20% -$312K 0.02% 366
2016
Q4 		$1.7M Buy
46,817
+4,379
+10% +$175K 0.03% 298
2016
Q3 		$1.95M Sell
42,438
-2,864
-6% -$149K 0.03% 274
2016
Q2 		$2.28M Sell
45,302
-30
-0.1% -$1.6K 0.04% 259
2016
Q1 		$2.43M Buy
45,332
+7,132
+19% +$418K 0.04% 244
2015
Q4 		$2.51M Sell
38,200
-10,038
-21% -$620K 0.04% 236
2015
Q3 		$2.72M Sell
48,238
-3,850
-7% -$250K 0.05% 237
2015
Q2 		$3.08M Buy
52,088
+3,165
+6% +$195K 0.05% 237
2015
Q1 		$3.05M Buy
48,923
+73
+0.1% +$4.24K 0.05% 235
2014
Q4 		$2.81M Sell
48,850
-469
-1% -$26.1K 0.04% 239
2014
Q3 		$2.65M Buy
49,319
+1,033
+2% +$54.7K 0.04% 236
2014
Q2 		$2.53M Buy
48,286
+7,578
+19% +$387K 0.04% 247
2014
Q1 		$2.15M Sell
40,708
-3,118
-7% -$144K 0.04% 261
2013
Q4 		$1.76M Sell
43,826
-811
-2% -$31.9K 0.03% 282
2013
Q3 		$1.69M Sell
44,637
-16,271
-27% -$635K 0.03% 280
2013
Q2 		$2.39M Buy
+60,908
New +$2.37M 0.04% 227

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $299B AUM 27.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $5.48B AUM 3.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Commerce Bank's TEVA Position: Q2 2019 in Review

Commerce Bank sold out of Teva Pharmaceuticals (TEVA) in Q2 2019, closing a stake of 10,458 shares — an estimated $164K sold.

Commerce Bank first reported a position in TEVA in Q2 2013 and held it in 24 quarters. The position peaked at $3.08M in Q2 2015. 452 funds tracked by Wall St. Rank hold TEVA as of Q2 2019.

  • Commerce Bank reported no remaining Teva Pharmaceuticals position as of Q2 2019 after selling out during the quarter.
  • Commerce Bank sold 10,458 Teva Pharmaceuticals shares in Q2 2019, an estimated $164K.
  • Commerce Bank first reported a position in Teva Pharmaceuticals in Q2 2013 and held it in 24 quarters.
  • Commerce Bank's Teva Pharmaceuticals position peaked at $3.08M in Q2 2015.
  • 452 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2019.

Based on Commerce Bank's 13F filing for Q2 2019, filed 7 Aug 2019.